Skip to main content

Community Benefit

By Jeff Lagasse | 12:58 pm | April 21, 2021
The move taps into the small business market in Connecticut and seeks to introduce more choice in coverage options.
By Jeff Lagasse | 11:45 am | April 20, 2021
Lack of transportation is a social determinant that is especially prevalent among economically disadvantaged communities.
By Jeff Lagasse | 04:34 pm | April 19, 2021
The J&J scientists said that out of 75,000 participants in a clinical trial, there was just one case of cerebral venous sinus thrombosis.
By Jeff Lagasse | 01:50 pm | April 19, 2021
While none are officially FDA approved, the agency has cleared them under emergency use authorization.
By Jeff Lagasse | 04:29 pm | April 16, 2021
Round 2 is a $249.95 million federal initiative that builds on the $200 million program established as part of the CARES Act.
By Jeff Lagasse | 11:19 am | April 09, 2021
Officials stress that the reactions fell within the normal range and found "no cause for concern."
By Jeff Lagasse | 03:28 pm | April 08, 2021
Vaccine confidence is increasing, but more needs to be done to convince Americans to get their shots.
By Mallory Hackett | 05:59 pm | April 02, 2021
The plan would spend $400 billion toward expanding access to home-based or community-based care and improving the wages of caregivers.  
By Jeff Lagasse | 12:51 pm | April 02, 2021
Two communities will receive an at-home test, and their data will be compared to that of communities who lack access to tests.
By Mallory Hackett | 06:15 pm | April 01, 2021
Also: Johnson & Johnson vaccine shipments have been delayed after cross-contamination occurred in a Baltimore production facility.